Exploration of Pharmacological Mechanism of Cinnamomum tamala Essential Oil in Treating Inflammation based on Network Pharmacology, Molecular Modelling, and Experimental Validation


Cite item

Full Text

Abstract

Background:Cinnamomum tamala (Buch.-Ham.) T.Nees & Eberm., also known as Indian bay leaf, holds a distinctive position in complementary and alternative medicinal systems due to its anti-inflammatory properties. However, the active constituents and key molecular targets by which C. tamala essential oil (CTEO) exerts its anti-inflammatory action remain unclear.

Objective:The present study used network pharmacology and experimental validation to investigate the mechanism of CTEO in the treatment of inflammation.

Methods:GC-MS analysis was used to identify the constituents of CTEO. The key constituents and core targets of CTEO against inflammation were obtained by network pharmacology. The binding mechanism between the active compounds and inflammatory genes was ascertained by molecular docking and molecular dynamics simulation analysis. The pharmacological mechanism predicted by network pharmacology was verified in lipopolysaccharide-stimulated murine macrophage (RAW 264.7) cell lines.

Results:Forty-nine constituents were identified by GC-MS analysis, with 44 constituents being drug-like candidates. A total of 549 compounds and 213 inflammation-related genes were obtained, revealing 68 overlapping genes between them. Compound target network analysis revealed cinnamaldehyde as the core bioactive compound with the highest degree score. PPI network analysis demonstrated Il-1β, TNF-α, IL8, IL6 and TLR4 as key hub anti-inflammatory targets. KEGG enrichment analysis revealed a Toll-like receptor signalling pathway as the principally regulated pathway associated with inflammation. A molecular docking study showed that cinnamaldehyde strongly interacted with the Il-1β, TNF-α and TLR-4 proteins. Molecular dynamics simulations and MMPBSA analysis revealed that these complexes are stable without much deviation and have better free energy values. In cellular experiments, CTEO showed no cytotoxic effects on RAW 264.7 murine macrophages. The cells treated with LPS exhibited significant reductions in NO, PGE2, IL-6, TNF-α, and IL-1β levels following treatment with CTEO. Additionally, CTEO treatment reduced the ROS levels and increased the antioxidant enzymes such as SOD, GSH, GPx and CAT. Immunofluorescence analysis revealed that CTEO inhibited LPS-stimulated NF-κB nuclear translocation. The mRNA expression of TLR4, MyD88 and TRAF6 in the CTEO group decreased significantly compared to the LPS-treated group.

Conclusion:The current findings suggest that CTEO attenuates inflammation by regulating TLR4/MyD88/NF- κB signalling pathway.

About the authors

Debajani Mohanty

Centre for Biotechnology, Siksha ‘O’ Anusandhan (Deemed to be University)

Email: info@benthamscience.net

Sucheesmita Padhee

Centre for Biotechnology, Siksha ‘O’ Anusandhan (Deemed to be University)

Email: info@benthamscience.net

Sudipta Jena

Centre for Biotechnology, Siksha ‘O’ Anusandhan (Deemed to be University)

Email: info@benthamscience.net

Ambika Sahoo

Centre for Biotechnology, Siksha ‘O’ Anusandhan (Deemed to be University)

Email: info@benthamscience.net

Pratap Panda

Centre for Biotechnology, Siksha ‘O’ Anusandhan (Deemed to be University)

Email: info@benthamscience.net

Sanghamitra Nayak

Centre for Biotechnology, Siksha ‘O’ Anusandhan (Deemed to be University)

Email: info@benthamscience.net

Asit Ray

Centre for Biotechnology, Siksha ‘O’ Anusandhan (Deemed to be University)

Author for correspondence.
Email: info@benthamscience.net

References

  1. Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med 2019; 25(12): 1822-32. doi: 10.1038/s41591-019-0675-0 PMID: 31806905
  2. El-Banna AA, Darwish RS, Ghareeb DA, Yassin AM, Abdulmalek SA, Dawood HM. Metabolic profiling of Lantana camara L. using UPLC-MS/MS and revealing its inflammation-related targets using network pharmacology-based and molecular docking analyses. Sci Rep 2022; 12(1): 14828. doi: 10.1038/s41598-022-19137-0 PMID: 36050423
  3. Raka RN, Zhiqian D, Yue Y, et al. Pingyin rose essential oil alleviates LPS-induced inflammation in RAW 264.7 cells via the NF-κB pathway: An integrated in vitro and network pharmacology analysis. BMC Complement Med Ther 2022; 22(1): 272. doi: 10.1186/s12906-022-03748-1 PMID: 36242028
  4. Labonte AC, Tosello-Trampont AC, Hahn YS. The role of macrophage polarization in infectious and inflammatory diseases. Mol Cells 2014; 37(4): 275-85. doi: 10.14348/molcells.2014.2374 PMID: 24625576
  5. Park C, Cha HJ, Lee H, Kim GY, Choi YH. The regulation of the TLR4/NF-κB and Nrf2/HO-1 signaling pathways is involved in the inhibition of lipopolysaccharide-induced inflammation and oxidative reactions by morroniside in RAW 264.7 macrophages. Arch Biochem Biophys 2021; 706: 108926. doi: 10.1016/j.abb.2021.108926 PMID: 34029560
  6. Ajmone-Cat MA, Bernardo A, Greco A, Minghetti L. Non-steroidal anti-inflammatory drugs and brain inflammation: Effects on microglial functions. Pharmaceuticals (Basel) 2010; 3(6): 1949-65. doi: 10.3390/ph3061949 PMID: 27713336
  7. Bost JW, Maroon A, Maroon J. Natural anti-inflammatory agents for pain relief. Surg Neurol Int 2010; 1(1): 80. doi: 10.4103/2152-7806.73804 PMID: 21206541
  8. Wang RX, Zhou M, Ma HL, Qiao YB, Li QS. The role of chronic inflammation in various diseases and anti-inflammatory therapies containing natural products. ChemMedChem 2021; 16(10): 1576-92. doi: 10.1002/cmdc.202000996 PMID: 33528076
  9. Baruah A, Nath SC, Hazarika AK. Investigation of the essential oils of Cinnamomum tamala Nees. Indian Perfumer 2007; 51(3): 50-2.
  10. Upadhyay RK. Therapeutic and pharmaceutical potential of Cinnamomum tamala. Res Rev Pharm Pharm Sci 2017; 6(3): 18-28.
  11. Gambhire MN, Juvekar AR, Wankhede SS. Anti-inflammatory activity of aqueous extract of Cinnamomum tamala leaves by in vivo and in vitro methods. J Pharm Res 2009; 2(9): 1521-4.
  12. Chaurasia JK, Tripathi YB. Chemical characterization of various fractions of leaves of Cinnamomum tamala Linn toward their antioxidant, hypoglycemic, and anti-inflammatory property. Immunopharmacol Immunotoxicol 2011; 33(3): 466-72. doi: 10.3109/08923973.2010.538850 PMID: 21175398
  13. Ni M, Liu X, Meng Z, et al. A bioinformatics investigation into the pharmacological mechanisms of javanica oil emulsion injection in non-small cell lung cancer based on network pharmacology methodologies. BMC Complement Med Ther 2020; 20(1): 174. doi: 10.1186/s12906-020-02939-y
  14. Mohanty D, Padhee S, Priyadarshini A, et al. Elucidating the anti-cancer potential of Cinnamomum tamala essential oil against non-small cell lung cancer: A multifaceted approach involving GC-MS profiling, network pharmacology, and molecular dynamics simulations. Heliyon 2024; 10(6): e28026. doi: 10.1016/j.heliyon.2024.e28026 PMID: 38533033
  15. Adams RP. Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy. Carol Stream, IL, USA: Allured Publishing Corporation 2007.
  16. Chou ST, Peng HY, Hsu JC, Lin CC, Shih Y. Achillea millefolium L. essential oil inhibits LPS-induced oxidative stress and nitric oxide production in RAW 264.7 macrophages. Int J Mol Sci 2013; 14(7): 12978-93. doi: 10.3390/ijms140712978 PMID: 23797659
  17. Chao LK, Hua KF, Hsu HY, et al. Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food Chem Toxicol 2008; 46(1): 220-31. doi: 10.1016/j.fct.2007.07.016 PMID: 17868967
  18. Kim BH, Lee YG, Lee J, Lee JY, Cho JY. Regulatory effect of cinnamaldehyde on monocyte/macrophage-mediated inflammatory responses. Mediators Inflamm 2010; 2010: 529359. doi: 10.1155/2010/529359
  19. Chen P, Zhou J, Ruan A, Zeng L, Liu J, Wang Q. Cinnamic aldehyde, the main monomer component of cinnamon, exhibits anti-inflammatory property in OA synovial fibroblasts via TLR4/MyD88 pathway. J Cell Mol Med 2022; 26(3): 913-24. doi: 10.1111/jcmm.17148 PMID: 34964259
  20. Banerjee P, Kemmler E, Dunkel M, Preissner R. ProTox 3.0: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 2024; 52(W1): W513-20. doi: 10.1093/nar/gkae303 PMID: 38647086
  21. Raies AB, Bajic VB. In silico toxicology: Computational methods for the prediction of chemical toxicity. Wiley Interdiscip Rev Comput Mol Sci 2016; 6(2): 147-72. doi: 10.1002/wcms.1240 PMID: 27066112
  22. Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin 2007; 45(2): 27-37. doi: 10.1097/AIA.0b013e318034194e PMID: 17426506
  23. Kuzmich N, Sivak K, Chubarev V, Porozov Y, Savateeva-Lyubimova T, Peri F. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines (Basel) 2017; 5(4): 34. doi: 10.3390/vaccines5040034 PMID: 28976923
  24. Kollias G. TNF pathophysiology in murine models of chronic inflammation and autoimmunity. Semin Arthritis Rheum 2005; 34(5): 3-6. doi: 10.1016/j.semarthrit.2005.01.002 PMID: 15852247
  25. Wei J, Zhang Y, Li H, Wang F, Yao S. Toll-like receptor 4: A potential therapeutic target for multiple human diseases. Biomed Pharmacother 2023; 166: 115338. doi: 10.1016/j.biopha.2023.115338 PMID: 37595428
  26. Molteni M, Gemma S, Rossetti C. The role of toll-like receptor 4 in infectious and noninfectious inflammation. Mediators Inflamm 2016; 2016: 6978936. doi: 10.1155/2016/6978936
  27. Salvador B, Arranz A, Francisco S, et al. Modulation of endothelial function by toll like receptors. Pharmacol Res 2016; 108: 46-56. doi: 10.1016/j.phrs.2016.03.038 PMID: 27073018
  28. Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci 2019; 20(23): 6008. doi: 10.3390/ijms20236008 PMID: 31795299
  29. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006; 8(Suppl 2): S3. doi: 10.1186/ar1917 PMID: 16899107
  30. Qazi BS, Tang K, Qazi A. Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis. Int J Inflamm 2011; 2011: 1-13. doi: 10.4061/2011/908468 PMID: 22235381
  31. Ren K, Torres R. Role of interleukin-1β during pain and inflammation. Brain Res Brain Res Rev 2009; 60(1): 57-64. doi: 10.1016/j.brainresrev.2008.12.020 PMID: 19166877
  32. Zuo X, Gu Y, Wang C, et al. A systematic review of the anti-inflammatory and immunomodulatory properties of 16 essential oils of herbs. Evid Based Complement Alternat Med 2020; 2020: 1-14. doi: 10.1155/2020/8878927 PMID: 33354224
  33. Liao J, Xie X, Wang W, et al. Anti-inflammatory activity of essential oil from leaves of Blumea balsamifera (L.) DC through inhibiting TLR4/NF-kB signaling pathways and NLRP3 inflammasome activation in LPS-induced RAW 264.7 macrophage cells. J Essent Oil-Bear Plants 2021; 24(2): 160-76. doi: 10.1080/0972060X.2021.1912645
  34. Tian Y, Zhou S, Takeda R, Okazaki K, Sekita M, Sakamoto K. Anti-inflammatory activities of amber extract in lipopolysaccharide-induced RAW 264.7 macrophages. Biomed Pharmacother 2021; 141: 111854. doi: 10.1016/j.biopha.2021.111854 PMID: 34229253
  35. Nakanishi M, Rosenberg DW. Multifaceted roles of PGE2 in inflammation and cancer. Semin Immunopathol 2013; 35(2): 123-37. doi: 10.1007/s00281-012-0342-8 PMID: 22996682
  36. Yao C, Narumiya S. Prostaglandin-cytokine crosstalk in chronic inflammation. Br J Pharmacol 2019; 176(3): 337-54. doi: 10.1111/bph.14530 PMID: 30381825
  37. Forman HJ, Zhang H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat Rev Drug Discov 2021; 20(9): 689-709. doi: 10.1038/s41573-021-00233-1 PMID: 34194012
  38. Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 2014; 20(7): 1126-67. doi: 10.1089/ars.2012.5149
  39. Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther 2017; 2(1): 17023. doi: 10.1038/sigtrans.2017.23 PMID: 29158945
  40. Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-κB signaling in inflammation and cancer. MedComm 2021; 2(4): 618-53. doi: 10.1002/mco2.104 PMID: 34977871
  41. Cheng C, Zou Y, Peng J. Oregano essential oil attenuates RAW 264.7 cells from lipopolysaccharide-induced inflammatory response through regulating NADPH oxidase activation-driven oxidative stress. Molecules 2018; 23(8): 1857. doi: 10.3390/molecules23081857 PMID: 30049950

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers